Clinical Lymphoma Myeloma & Leukemia

Clinical Lymphoma Myeloma & Leukemia is a subscription (hybrid open access) journal published by Elsevier BV in the United States. OpenAlex counts 20,346 works from it, cited 51,698 times; its h-index is 69. Its two-year mean citedness, which is computed the way the impact factor is, is 0.39: a paper it published in the two years before was cited about 0.39 times last year. It published 3,472 papers in 2025, up 58% from 2,198 in 2024. Publishing a paper open access in it costs about US$3,890.

Publisher
Elsevier BV
Citations per paper
0.39 two-year mean, OpenAlex
h-index
69 i10-index 1,498
Access
Subscription · hybrid open access
APC
US$3,890 to publish open access
ISSN
2152-2669, 2152-2650
Country
United States
Works published
20,346 cited 51,698 times
Papers in 2025
3,472
Field
Medicine
Website
Journal home ↗

Clinical Lymphoma Myeloma & Leukemia year by year

Papers it published each year, and the citations all its papers received that year.

YearPapers publishedCitations received
2026 so far3,8725,558
20253,4726,257
20242,1985,452
20232,0015,472
20221,5755,097
20211,3954,914
20207004,086
20191,2633,056

What Clinical Lymphoma Myeloma & Leukemia publishes

Its most frequent research topics, by OpenAlex's topic classification.

Questions about Clinical Lymphoma Myeloma & Leukemia

What is the impact factor of Clinical Lymphoma Myeloma & Leukemia?

Clarivate's Journal Impact Factor is licensed and not shown here. OpenAlex's two-year mean citedness, computed the same way from open data, is 0.39 for Clinical Lymphoma Myeloma & Leukemia: on average, each paper it published in the two years before was cited about 0.39 times in a year.

What is the h-index of Clinical Lymphoma Myeloma & Leukemia?

69, by OpenAlex's count: 69 of its papers have each been cited at least 69 times. Its i10-index is 1,498.

Is Clinical Lymphoma Myeloma & Leukemia open access?

Not fully. Clinical Lymphoma Myeloma & Leukemia is a subscription journal; a paper is free to read when its authors paid for open access or posted a copy in a repository.

What is the publication fee (APC) of Clinical Lymphoma Myeloma & Leukemia?

About US$3,890, which is the fee to publish a paper open access as listed by OpenAlex. Fees change and waivers exist, so check the journal's own page before you submit.

What is the ISSN of Clinical Lymphoma Myeloma & Leukemia?

Its linking ISSN is 2152-2669; all its ISSNs: 2152-2669, 2152-2650.

Who publishes Clinical Lymphoma Myeloma & Leukemia?

Elsevier BV, based in the United States.

How many papers does Clinical Lymphoma Myeloma & Leukemia publish a year?

3,472 in 2025, by OpenAlex's count of what it published that year.

What does Clinical Lymphoma Myeloma & Leukemia publish?

Its most frequent research topics are Multiple Myeloma Research and Treatments, Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, in the field of Medicine.

Is Clinical Lymphoma Myeloma & Leukemia a predatory journal?

Nothing in the scholarly indexes suggests so. Clinical Lymphoma Myeloma & Leukemia is on OpenAlex's list of core sources, journals with peer review and an editorial board, it has published 20,346 works cited 51,698 times. For a journal you do not know, check the red flags with our predatory journal checker.

Is Clinical Lymphoma Myeloma & Leukemia indexed in Scopus or Web of Science?

Check the Scopus Sources list and Clarivate's Master Journal List by its ISSN (2152-2669): both are free to search. Our guide on checking journal indexing shows each step.

Journals like Clinical Lymphoma Myeloma & Leukemia

Other Medicine journals with a similar impact.

Every Medicine journal, ranked · The journal directory

Journal data from OpenAlex (CC0), compiled 21 November 2026. Download the whole directory as a CSV file (CC BY 4.0).